NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE276395 Query DataSets for GSE276395
Status Public on Nov 24, 2024
Title Gene expression dysregulation in whole blood of patients with C. difficile infection
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Background: Clostridioides difficile (C. difficile) is a global threat and has significant implications for individuals and health care systems. Little is known about host molecular mechanisms and transcriptional changes in peripheral immune cells. This is the first gene expression study in whole blood of patients with C. difficile infection. Methods: We took blood and stool samples from patients with toxigenic C. difficile infection (CDI), non-toxigenic C. difficile infection (GDH), inflammatory bowel disease (IBD), diarrhoea from other causes (DC) and healthy controls (HC). We performed transcriptome-wide RNA profiling on peripheral blood to identify diarrhoea common and CDI unique gene sets. Results: Diarrhoea groups upregulated innate immune responses with neutrophils at the epicentre. The common signature associated with diarrhoea was non-specific and shared by various other inflammatory conditions. CDI had a unique 45-gene set reflecting downregulation of humoral and T cell memory functions. Dysregulation of immunometabolic genes was also abundant and linked to immune cell fate during differentiation. Conclusions: Whole transcriptome analysis of white cells in blood from patients with toxigenic C. difficile infection showed that there is an impairment of adaptive immunity and immunometabolism.
 
Overall design 278 whole blood samples were assayed, with some participants in the CDI group also measured ~2 weeks post-baseline. In total there are 78 samples from the CDI group at baseline, plus 27 at the 2-week time point; 45 samples from the diarrhoea from other causes (DC) group; 37 samples from the non-toxigenic C. difficile infection (GDH) group; 40 from the inflammatory bowel disease (IBD) group and 51 from the healthy control (HC) group.
 
Contributor(s) Tsakiroglou M, Evans A, Carracedo AD, Little M, Hornby R, Roberts P, Zhang E, Miyajima F, Pirmohamed M
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Sep 05, 2024
Last update date Nov 25, 2024
Contact name Maria Tsakiroglou
Organization name University of Liverpool
Department Department of Pharmacology and Therapeutics
Street address Block A, Waterhouse Building, 1-5 Brownlow Street,
City Liverpool
ZIP/Postal code L69 3GL
Country United Kingdom
 
Platforms (1)
GPL23126 [Clariom_D_Human] Affymetrix Human Clariom D Assay [transcript (gene) version]
Samples (278)
GSM8497748 blood-CDH_639364_0wk
GSM8497749 blood-CDH_888066_0wk
GSM8497750 blood-CDH_135248_0wk
Relations
BioProject PRJNA1157210

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE276395_RAW.tar 6.2 Gb (http)(custom) TAR (of CEL)

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap